Risperidone in the treatment of schizophrenia.: A therapy study.

被引：0
|
作者：
Stuppäck, CH [1 ]
机构：
[1] Landesnervenklin Salzburg, Psychiat Abt 1, A-5020 Salzburg, Austria
来源：
NEUROPSYCHIATRIE | 1999年 / 13卷 / 01期
关键词：
risperidone; schizophrenia; therapy study;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
260 in- and outpatients suffering from schizophrenia were included in a therapy study with Risperidone. The mean daily dose amounted to 3.9 mg. The mean treatment periode was 104 days (s.d. +/- 61). Patients showed a statistically significant decrease in the rating scales used (CGI, BPRS, PANSS). Risperidone was very well tolerated, only 4.2% of the patients had to be withdrawn due to side effects. Another important result of the study presented is, that extrapyramidal motoric symptoms decreased significantly during the treatment with Risperidone. Rispsridone proved to be effective in schizophrenic patients against positive as well as negative symptoms and showed a favourable side effect profile.
引用
收藏
页码：18 / 22
页数：5
相关论文
共 50 条
  • [41] Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia
    Takahashi, N
    Terao, T
    Oga, T
    Okada, M
    NEUROPSYCHOBIOLOGY, 1999, 39 (02) : 81 - 85
  • [42] Risperidone - A novel serotonin-dopamine antagonist in the treatment of schizophrenia
    Franz, M
    Gallhofer, B
    PSYCHOPHARMAKOTHERAPIE, 1997, 4 (02): : 54 - 58
  • [43] Ambulatory use of olanzapine and risperidone:: A population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia
    Cooper, D
    Moisan, J
    Gaudet, M
    Abdous, B
    Grégoire, JP
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (14): : 901 - 908
  • [44] Nature and schizophrenia.
    Camacho, EB
    León, EC
    Uribe, MPO
    SALUD MENTAL, 2005, 28 (02) : 59 - 72
  • [45] Hippocampal volume in schizophrenia and its relationship with risperidone treatment: A stereological study
    Savas, HA
    Unal, B
    Erbagci, H
    Inaloz, S
    Herken, H
    Canan, S
    Gumusburun, E
    Zoroglu, SS
    NEUROPSYCHOBIOLOGY, 2002, 46 (02) : 61 - 66
  • [46] A comparative study of clinical and psychotherapeutic implications in the biopsychological treatment of schizophrenia.: Part one
    Valencia, M
    Ortega-Soto, HA
    Rodríguez, MS
    Gómez, L
    SALUD MENTAL, 2004, 27 (03) : 47 - 53
  • [47] Menstrual Dysfunction in Women With Schizophrenia During Risperidone Maintenance Treatment
    Bo, Qijing
    Xing, Xiaomeng
    Li, Tian
    Mao, Zhen
    Zhou, Fuchun
    Wang, Chuanyue
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (02) : 135 - 139
  • [48] Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia
    Peuskens, J
    Bech, P
    Möller, HJ
    Bale, R
    Fleurot, O
    Rein, W
    PSYCHIATRY RESEARCH, 1999, 88 (02) : 107 - 117
  • [49] Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: A switch study
    Wang, Xiaohong
    Savage, Robert
    Borisov, Andrey
    Rosenberg, Jill
    Woolwine, Bobbi
    Tucker, Melanie
    May, Roberta
    Feldman, Jacqueline
    Nemeroff, Charles B.
    Miller, Andrew H.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2006, 40 (07) : 669 - 676
  • [50] Risperidone in acute and long-term therapy of schizophrenia - a clinical profile
    Pajonk, FG
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (01) : 15 - 23
12345